Skip to main content
. 2019;20(6):1809–1815. doi: 10.31557/APJCP.2019.20.6.1809

Table 6.

Comparation of Previous Studies

Author (yr) N Baseline p16 IHC (%) F/U time (mo.) Progress CIN2+ Results
Razmpoosh (2014)(15) 64 CIN1 27.4 > 6 25.00% p = 0.002
Liao (2014)(16) 171 Normal 42.7 24 10.70% RR 8.25 (1.02-66.62)
CIN1
Pacchiarotti (2014)(17) 124 Normal 50.8 24 10.30% RR 5.20 (0.60-47.50)
CIN1
Sagasta (2016)(18) 416 HPV 11.3 28 22.40% HR 1.6 (0.9–2.6)
CIN1
This study 108 HPV 22.2 22 16.70% HR 5.29 (1.18-23.76)
CIN1